Green Cross Holdings Corporation (KRX:005250)

Market Cap	768.65B
Revenue (ttm)	2.40T
Net Income (ttm)	127.58B
Shares Out	45.40M
EPS (ttm)	2,832.40
PE Ratio	5.98
Forward PE	n/a
Dividend	500.00 (2.96%)
Ex-Dividend Date	Dec 27, 2024

Volume	75,829
Average Volume	90,793
Open	16,860
Previous Close	16,910
Day's Range	16,820 - 17,070
52-Week Range	12,000 - 18,050
Beta	0.68
RSI	60.10
Earnings Date	Feb 10, 2026

About Green Cross Holdings

Green Cross Holdings Corporation operates as a biotechnology company. The company provides prescription drugs and over the counter drugs; aseptic fill and finish services for drug manufacturing; and pharmaceutical logistics services. It also researches and develops plasma derivatives for von Willebrand disease and primary immunodeficiency; vaccines for mRNA flu, anthrax, tetanus, diphtheria, pertussis, tuberculosis, and varicella; recombinant treatments for acquired thrombotic thrombocytopenic purpura, fabry, hemophilia, hunterase, colon cancer...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1967
• Employees: 144
• Stock Exchange: Korea Stock Exchange
• Ticker Symbol: 005250